Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Pharmacotherapy
|
April 22, 1999
A graphic nomogram for warfarin dosage adjustment
G M Dalere, R W Coleman, B L Lum
Cancer Research
|
December 15, 1989
Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells
M P Gosland, B L Lum, B I Sikic
Drug Intelligence & Clinical Pharmacy
|
April 1, 1985
Doxorubicin: alteration of dose scheduling as a means of reducing cardiotoxicity
B L Lum, J M Svec, F M Torti
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Effect of different mathematical methods on etoposide area under the curve estimations and pharmacodynamic response predictions
D L McCauley, B L Lum, B I Sikic
American Pharmacy
|
July 1, 1989
Cancer detection and the community pharmacist
B L Lum, D S McWaters, M A Mergener
Cancer Treatment and Research
|
January 1, 1995
The reversal of multidrug resistance
G A Fisher, B L Lum, B I Sikic
Pharmacotherapy
|
July 1, 1997
Dihydropyrimidine dehydrogenase deficiency: a potential etiology for 5-fluorouracil-induced neurotoxicity
M E Risso, N K Hasson, B L Lum
The Annals of Pharmacotherapy
|
September 20, 1997
Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy
A T Le, N K Hasson, B L Lum
Journal of Clinical Pharmacology
|
October 1, 1992
Arithmetic versus harmonic mean values for cyclosporin-A pharmacokinetic parameters
B L Lum, J Tam, S Kaubisch, et al.
Journal of Clinical Pharmacology
|
March 1, 1994
Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis
G F Cooney, B L Lum, M Tomaselli, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Pharmacotherapy
|
April 22, 1999
A graphic nomogram for warfarin dosage adjustment
G M Dalere, R W Coleman, B L Lum
Cancer Research
|
December 15, 1989
Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells
M P Gosland, B L Lum, B I Sikic
Drug Intelligence & Clinical Pharmacy
|
April 1, 1985
Doxorubicin: alteration of dose scheduling as a means of reducing cardiotoxicity
B L Lum, J M Svec, F M Torti
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Effect of different mathematical methods on etoposide area under the curve estimations and pharmacodynamic response predictions
D L McCauley, B L Lum, B I Sikic
American Pharmacy
|
July 1, 1989
Cancer detection and the community pharmacist
B L Lum, D S McWaters, M A Mergener
Cancer Treatment and Research
|
January 1, 1995
The reversal of multidrug resistance
G A Fisher, B L Lum, B I Sikic
Pharmacotherapy
|
July 1, 1997
Dihydropyrimidine dehydrogenase deficiency: a potential etiology for 5-fluorouracil-induced neurotoxicity
M E Risso, N K Hasson, B L Lum
The Annals of Pharmacotherapy
|
September 20, 1997
Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy
A T Le, N K Hasson, B L Lum
Journal of Clinical Pharmacology
|
October 1, 1992
Arithmetic versus harmonic mean values for cyclosporin-A pharmacokinetic parameters
B L Lum, J Tam, S Kaubisch, et al.
Journal of Clinical Pharmacology
|
March 1, 1994
Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis
G F Cooney, B L Lum, M Tomaselli, et al.
Page
of 6